Malaria

  • Your Selections:

Refine Results

date

Tags

Donors Pledge Nearly $12B For Global Fund, Missing Lowest Funding Target

Donors at a replenishment meeting in New York on Tuesday pledged $11.7 billion over three years for the Global Fund to Fight AIDS, Tuberculosis and Malaria, “higher than past support but below the lowest target set by the agency in its efforts to combat disease in the developing world,” the Financial Times reports (Jack, 10/5).

Also In Global Health News: Flooding, HIV Treatment Adherence, and Economic Growth In Africa; China Detects Superbug; U.S. Aid To Myanmar; Cash-Transfer Programs

1.8M Now Affected By Flooding In West And Central Africa; Hardest Hit-Benin Struggles With Disease, Damaged Health Centers Flooding continues to devastate Central and West Africa – more than 1.8 million people have been affected and 400 killed, according to the U.N., United Press International reports. “The nation of Benin has…

Opinions: Canada’s Role In Global Health; Drug Licensing Agreements Promote Drug Access; Funding For USAID, State; Haiti

Canada Must Lead To Ensure Robust Efforts In Global Fight Against HIV/AIDS, TB, Malaria After outlining the work of the Global Fund to Fight AIDS, Tuberculosis and Malaria, Michel Kazatchkine, the organization’s executive director, highlights the role Canada can play in determining “whether the world can overcome AIDS, tuberculosis and malaria”…

TIME Series Examines Global Health

As part of a special package about global health, TIME magazine visits what is known as “the most malarial town on earth” – Apac, Uganda – and examines global malaria control and efforts to eradicate the disease.

Recent, Upcoming FDA Efforts Address Rare, ‘Neglected’ Diseases

The FDA’s new rare disease review group will hold its first public hearing on Tuesday and Wednesday to discuss how to expand efforts to develop treatments for rare diseases that affect fewer than 200,000 people, Reuters. “The new rare disease review group is part of a broadened effort to encourage companies to spend more money on the more than 6,000 rare diseases identified,” Reuters writes, adding that the FDA “already offer[s] companies grants and guaranties seven years of market exclusivity for drugs that treat rare diseases.”

Media Outlets Examine Efforts To Develop Malaria Vaccines

Scientists have identified a group of proteins they say could form the basis of a malaria vaccine, Australia’s ABC News reports. “However, they say more laboratory work and clinical trials need to be done, with a vaccine at least 10 years away,” the news service reports (Macey, 1/19).

Also In Global Health News: Dengue Vaccine; Medicines For Poor; Gates New Ag Development Director; USDA Efforts In Afghanistan; Soccer And Malaria

Experimental Dengue Vaccine Shows Promise In Clinical Trial Of Adults An experimental dengue vaccine created by the drugmaker Sanofi-Aventis protected a group of healthy adults from all four strains of the virus, “bringing the drugmaker closer to providing the first vaccine against a disease that threatens 40 percent of the…

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.